Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Alkem Labs Slapped Rs 2.34 Cr GST Demand in Goa

Anti-infective for severe fungal infections: Alkem Labs joins hands with Biosergen for development of BSG005

Ruchika Sharma25 Sept 2023 2:30 PM IST

Alkem will invest in the clinical development of BSG005 and will be granted an exclusive license to market it in India.

Perioperative regimen of neoadjuvant Opdivo, chemotherapy improves event free survival in Resectable Non-Small Cell Lung Cancer: Bristol Myers Squibb

Ruchika Sharma25 Sept 2023 1:30 PM IST

Princeton: Bristol Myers Squibb has announced the Phase 3 CheckMate -77T trial has met its primary endpoint of improved event-free survival...

Biogen, Eisai get Japanese nod for Leqembi Intravenous Infusion for Alzheimer's Disease

Ruchika Sharma25 Sept 2023 12:30 PM IST

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody LEQEMBI...

Strides Pharma Science Singapore arm gets USFDA nod for Icosapent Ethyl Capsules to reduce heart issues

Ruchika Sharma25 Sept 2023 11:21 AM IST

Icosapent Ethyl Capsule is a prescription medication used in conjunction with other medicines like statins to reduce the risk of heart attack, stroke...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck Keytruda plus Padcev improves survival in advanced or metastatic urothelial carcinoma

Ruchika Sharma24 Sept 2023 3:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the Phase 3 KEYNOTE-A39...

CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin Study

Abbott broadens access to cutting edge biosimilars in key emerging markets

Ruchika Sharma24 Sept 2023 12:30 PM IST

Abbott Park, Ill.: Abbott has announced an agreement with Spain-based mAbxience Holdings S.L. to commercialize several biosimilars focusing on...

Belgium based Eurofins inaugurates BioPharma Services Campus in Genome Valley

Ruchika Sharma24 Sept 2023 11:30 AM IST

Hyderabad: Belgium headquartered Eurofins, the world leader in testing for life, has inaugurated its state-of-the-art, BioPharma Services Campus in...

Caplin Point Labs reappoints Dr C K Gariyali as Independent director

Ruchika Sharma24 Sept 2023 10:00 AM IST

Chennai: Caplin Point Labs has announced that the members of the company have re-appointed Dr C K Gariyali as an Independent Director of the...

Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe Widens

Abbott India warns of Duphalac, Cremaffin syrup shortage

Ruchika Sharma23 Sept 2023 3:30 PM IST

Cremaffin, Abbott argued, is a "necessity to support hospitalised patients" while Duphalac is prescribed in serious disorders caused by liver failure.

Setback: Merck-Eisai combination therapy fails in lung cancer studies

Ruchika Sharma23 Sept 2023 2:21 PM IST

New Jersy: Drugmakers Merck and Eisai said on Friday a combination of their cancer therapies did not prolong the lives of patients in two...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Eli Lilly-Boehringer Ingelheim Jardiance gets USFDA approval for adults with chronic kidney disease

Ruchika Sharma23 Sept 2023 12:30 PM IST

Ridgefield: Eli Lilly and Company and Boehringer Ingelheim have announced that the U.S. Food and Drug Administration (FDA) has approved Jardiance...

USFDA nod to JnJ Tremfya for Crohns disease

Johnson & Johnson Vision launches SILK procedure performed with next generation laser vision correction solution in India

Ruchika Sharma23 Sept 2023 11:28 AM IST

The procedure is easy, performed using the next-generation laser vision correction solution that gently creates a small disk-shaped lens, called a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok